HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Francesco Albano Selected Research
Francesco Albano Research Topics
Disease
21
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2022 - 04/2007
17
Neoplasms (Cancer)
02/2022 - 10/2008
12
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2021 - 03/2008
11
Leukemia
01/2022 - 03/2013
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021 - 10/2004
7
Acute Promyelocytic Leukemia
01/2021 - 03/2006
6
Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 06/2010
6
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 03/2002
6
Philadelphia Chromosome
01/2021 - 08/2017
4
Residual Neoplasm
01/2021 - 10/2004
4
Melanoma (Melanoma, Malignant)
09/2020 - 04/2013
4
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2020 - 03/2014
4
Lymphoma (Lymphomas)
01/2019 - 09/2014
3
Disease Progression
12/2021 - 10/2017
2
Eosinophilia
02/2022 - 11/2019
2
Hematologic Diseases (Blood Diseases)
01/2022 - 12/2019
2
Graft vs Host Disease (Graft-Versus-Host Disease)
11/2021 - 03/2013
2
Multiple Myeloma
09/2020 - 10/2017
2
B-Cell Lymphoma (Lymphoma, B Cell)
09/2020 - 01/2016
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2020 - 01/2020
2
Genetic Translocation (Chromosomal Translocation)
09/2014 - 10/2008
2
Mitochondrial Diseases (Mitochondrial Disease)
04/2013 - 01/2010
1
Pheochromocytoma
05/2022
1
Second Primary Neoplasms (Neoplasms, Second)
03/2022
1
Chromosome Aberrations (Chromosome Abnormalities)
02/2022
1
Bronchiolitis Obliterans Syndrome
01/2022
1
Myeloid Leukemia (Leukemia, Myelocytic)
01/2022
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022
1
Genomic Instability
12/2021
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2021
1
Dyslipidemias (Dyslipidemia)
08/2021
1
Carcinogenesis
07/2021
1
Lymphoid Leukemia
07/2021
1
Chronic Disease (Chronic Diseases)
05/2021
1
Fatigue
05/2021
1
Fatty Liver
10/2020
1
Thyroid Neoplasms (Thyroid Cancer)
09/2020
1
Carcinoma (Carcinomatosis)
09/2020
1
Hypertension (High Blood Pressure)
07/2020
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2020
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020
Drug/Important Bio-Agent (IBA)
15
Tyrosine Kinase Inhibitors
IBA
01/2021 - 03/2013
10
Biological Products
IBA
03/2022 - 03/2006
8
Imatinib Mesylate (Gleevec)
FDA Link
01/2021 - 04/2007
6
nilotinib
FDA Link
10/2022 - 03/2013
5
Pharmaceutical Preparations
IBA
07/2020 - 01/2010
4
Phosphotransferases (Kinase)
IBA
01/2021 - 01/2013
4
Dasatinib (BMS 354825)
FDA Link
01/2019 - 01/2013
3
Biomarkers (Surrogate Marker)
IBA
07/2021 - 10/2017
3
fludarabine
IBA
11/2020 - 02/2014
3
ponatinib
IBA
01/2020 - 01/2019
3
Tretinoin (Retinoic Acid)
FDA Link
Generic
01/2020 - 02/2017
2
Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)
IBA
02/2022 - 02/2008
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
02/2022 - 01/2021
2
LDL Lipoproteins (beta Lipoproteins)
IBA
08/2021 - 01/2020
2
MicroRNAs (MicroRNA)
IBA
07/2021 - 08/2012
2
Arsenic Trioxide (Trisenox)
FDA Link
01/2020 - 02/2017
2
Peptides (Polypeptides)
IBA
10/2017 - 01/2016
2
Proteins (Proteins, Gene)
FDA Link
11/2015 - 10/2014
2
Untranslated RNA (Noncoding RNA)
IBA
10/2015 - 10/2008
2
Antigens
IBA
12/2014 - 03/2002
2
Caspase 3 (Caspase-3)
IBA
10/2014 - 04/2013
2
Superoxide Dismutase
IBA
04/2013 - 01/2010
2
Diclofenac (SR 38)
FDA Link
Generic
04/2013 - 01/2010
1
3-Iodobenzylguanidine (Iobenguane)
IBA
05/2022
1
Catecholamines
IBA
05/2022
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
02/2022
1
Messenger RNA (mRNA)
IBA
01/2022
1
ibrutinib
IBA
01/2022
1
Antiviral Agents (Antivirals)
IBA
01/2022
1
fms-Like Tyrosine Kinase 3
IBA
01/2022
1
Interferon Regulatory Factors
IBA
12/2021
1
Tryptophan (L-Tryptophan)
FDA Link
12/2021
1
Nuclear Export Signals (Nuclear Export Signal)
IBA
12/2021
1
Protein C
IBA
12/2021
1
Nucleophosmin
IBA
12/2021
1
oxidized low density lipoprotein
IBA
08/2021
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
08/2021
1
Cell-Free Nucleic Acids
IBA
07/2021
1
Tyrosine (L-Tyrosine)
FDA Link
01/2021
1
Immunoglobulins (Immunoglobulin)
IBA
01/2021
1
ofatumumab
FDA Link
11/2020
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2020
1
Enzymes
IBA
10/2020
1
Lenalidomide (CC 5013)
FDA Link
09/2020
1
Immunomodulating Agents
IBA
09/2020
1
Angiotensin Receptor Antagonists
IBA
07/2020
1
Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
IBA
07/2020
1
HMGA Proteins
IBA
06/2020
1
Nucleic Acids
IBA
04/2020
1
Immunoglobulin Variable Region
IBA
03/2020
1
carboxyl radical (COO-)
IBA
01/2020
Therapy/Procedure
21
Therapeutics
07/2021 - 03/2008
5
Drug Therapy (Chemotherapy)
12/2021 - 01/2016
3
Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2022 - 03/2013
3
Precision Medicine
12/2021 - 10/2017
3
Transplantation
11/2021 - 03/2013
3
Aftercare (After-Treatment)
01/2020 - 04/2007
1
Homologous Transplantation
11/2021
1
Stem Cell Transplantation
11/2021